Here's What We Learned About The CEO Pay At Oxurion NV (EBR:OXUR)

Patrik De Haes became the CEO of Oxurion NV (EBR:OXUR) in 2008, and we think it's a good time to look at the executive's compensation against the backdrop of overall company performance. This analysis will also evaluate the appropriateness of CEO compensation when taking into account the earnings and shareholder returns of the company.

See our latest analysis for Oxurion

Advertisement

Comparing Oxurion NV's CEO Compensation With the industry

Our data indicates that Oxurion NV has a market capitalization of €98m, and total annual CEO compensation was reported as €557k for the year to December 2019. That is, the compensation was roughly the same as last year. We note that the salary portion, which stands at €469.0k constitutes the majority of total compensation received by the CEO.

On comparing similar-sized companies in the industry with market capitalizations below €169m, we found that the median total CEO compensation was €333k. This suggests that Patrik De Haes is paid more than the median for the industry.

Component20192018Proportion (2019)
Salary€469k€459k84%
Other€88k€90k16%
Total Compensation€557k €549k100%

Talking in terms of the industry, salary represented approximately 65% of total compensation out of all the companies we analyzed, while other remuneration made up 35% of the pie. It's interesting to note that Oxurion pays out a greater portion of remuneration through salary, compared to the industry. If salary dominates total compensation, it suggests that CEO compensation is leaning less towards the variable component, which is usually linked with performance.

ceo-compensation
ENXTBR:OXUR CEO Compensation August 21st 2020

A Look at Oxurion NV's Growth Numbers

Over the last three years, Oxurion NV has shrunk its earnings per share by 4.9% per year. In the last year, its revenue is down 26%.

Overall this is not a very positive result for shareholders. This is compounded by the fact revenue is actually down on last year. These factors suggest that the business performance wouldn't really justify a high pay packet for the CEO. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..

Has Oxurion NV Been A Good Investment?

Given the total shareholder loss of 17% over three years, many shareholders in Oxurion NV are probably rather dissatisfied, to say the least. This suggests it would be unwise for the company to pay the CEO too generously.

In Summary...

As we touched on above, Oxurion NV is currently paying its CEO higher than the median pay for CEOs of companies belonging to the same industry and with similar market capitalizations. Unfortunately, this doesn't look great when you see shareholder returns have been negative over the last three years. What's equally worrying is that the company isn't growing by our analysis. Understandably, the company's shareholders might have some questions about the CEO's remuneration, given the disappointing performance.

CEO pay is simply one of the many factors that need to be considered while examining business performance. That's why we did our research, and identified 4 warning signs for Oxurion (of which 1 can't be ignored!) that you should know about in order to have a holistic understanding of the stock.

Switching gears from Oxurion, if you're hunting for a pristine balance sheet and premium returns, this free list of high return, low debt companies is a great place to look.

If you decide to trade Oxurion, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

MI
mitchell_lawler
mitchell_lawler

The world's in stitches over robots sprinting into walls. I still think they're the answer to our productivity problem.

The world's in stitches over robots sprinting into walls. I still think they're the answer to our productivity problem. cover
77
DE
devon_jd150

What you have missed is that this event happened last year too. Last year the number was 21 seconds. This year it beat Bolt. That's 60% improvement in an year. Now extrapolate this in many axes of work that Robots can come and fill in. The physical productivity and AI boom is just starting.

LE
LeverageIsLovely

I can't pick a company. But I can pick a person. With no doubt that's Musk. Optimus for blue collar productivity increase and xAI for white collar productivity increase. Did anyone dabble with GrokBot here?

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
75

About ENXTBR:OXUR

Oxurion

A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.

Medium-low risk and slightly overvalued.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.575.5% undervalued
42 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5861.4% undervalued
63 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.1% undervalued
68 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11632.1% undervalued
14 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

LU
LunaRodas
SAIC logo
LunaRodas on Science Applications International ·

SAIC | Science Applications International: What They Said vs. What They Did

Fair Value:US$119.245.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
LOT logo
Anthony_Lee on Lotus Technology ·

Tech and Tradition: Lotus Technology’s Compound Formula in Luxury EVs

Fair Value:US$2.5351.0% undervalued
2 users have followed this narrative
5 users have commented on this narrative
1 users have liked this narrative
EP
DRY logo
Epstein_Research on Dryden Gold ·

Dryden Gold continues to expand & de-risk its flagship Gold Rock project!

Fair Value:CA$173.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
367 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9122.3% overvalued
213 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.1% undervalued
125 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative